Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $12.3500 (2.32%) ($12.0500 - $12.4400) on Tue. May. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.14% (three month average) | RSI | 42 | Latest Price | $12.3500(2.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -2% a day on average for past five trading days. | Weekly Trend | FOLD declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(60%) XBI(57%) IWO(55%) IWM(52%) IWC(50%) | Factors Impacting FOLD price | FOLD will decline at least -1.57% in a week (0% probabilities). VXX(-19%) TLT(-15%) IFRA(-9%) VIXM(-8%) TIP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.57% (StdDev 3.14%) | Hourly BBV | 0 () | Intraday Trend | 1.4% | | | |
|
1 - 5 Day Possible Target | $5.32(-56.92%) | Resistance Level | $13.19 | 5 Day Moving Average | $12.66(-2.45%) | 10 Day Moving Average | $13.18(-6.3%) | 20 Day Moving Average | $13.19(-6.37%) | To recent high | -14.2% | To recent low | 11.4% | Market Cap | $3.189b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |